Mauro Annese

1.4k total citations · 1 hit paper
14 papers, 1.0k citations indexed

About

Mauro Annese is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Mauro Annese has authored 14 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 9 papers in Epidemiology and 2 papers in Rheumatology. Recurrent topics in Mauro Annese's work include Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis B Virus Studies (7 papers). Mauro Annese is often cited by papers focused on Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis B Virus Studies (7 papers). Mauro Annese collaborates with scholars based in Italy, Brazil and United States. Mauro Annese's co-authors include Donato Bacca, Gaetano Scotto, Angelo Andriulli, F Zechini, Alessandra Mangia, Vito Carretta, Nicola Minerva, Rosanna Santoro, Marcello Persico and Fulvio Spirito and has published in prestigious journals such as New England Journal of Medicine, Hepatology and The American Journal of Medicine.

In The Last Decade

Mauro Annese

13 papers receiving 997 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Peginterferon Alfa-2b and Ribavirin for 12 vs. 24 Weeks in HCV Genotype 2 or 3

2005 608 citations Alessandra Mangia, Rosanna Santoro et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Mauro Annese

Since Specialization

Citations

This map shows the geographic impact of Mauro Annese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mauro Annese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mauro Annese more than expected).

Fields of papers citing papers by Mauro Annese

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mauro Annese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mauro Annese. The network helps show where Mauro Annese may publish in the future.

Co-authorship network of co-authors of Mauro Annese

This figure shows the co-authorship network connecting the top 25 collaborators of Mauro Annese. A scholar is included among the top collaborators of Mauro Annese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mauro Annese. Mauro Annese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Is faecal-immunochemical test useful in patients with iron deficiency anaemia and without overt bleeding? 2011 ·Digestive and Liver Disease ·(unknown), Angelo Zullo, Cesare Hassan, Lorenzo Ridola, Mauro Annese	16
2	Peginterferon Alfa-2b and Ribavirin for 12 vs. 24 Weeks in HCV Genotype 2 or 3 breakdown → 2005 ·New England Journal of Medicine ·Alessandra Mangia, Rosanna Santoro, Nicola Minerva, Giovanni Ricci, Vito Carretta, Marcello Persico, F. Vinelli, Gaetano Scotto, Donato Bacca, Mauro Annese, Mario Romano, F Zechini, Fernando Sogari, Fulvio Spirito, Angelo Andriulli	608
3	A randomized controlled trial of pegylated interferon α‐2a (40 KD) or interferon α‐2a plus ribavirin and amantadine vs interferon α‐2a and ribavirin in treatment‐naïve patients with chronic hepatitis C 2005 ·Journal of Viral Hepatitis ·Alessandra Mangia, Giorgio Ricci, Marcello Persico, (unknown), Vito Carretta, Donato Bacca, (unknown), M.L. Piattelli, Mauro Annese, Giuseppe Di Maio, D. Conte, Vincenzo Guadagnino, Valerio Pazienza, Davide Festi, Federica Di Spirito, Angelo Andriulli	42
4	93 HCV genotype 2 and 3 can be cured by PEG-IFN-alfa-2B and RBV for 12 wks: A randomized controlled study 2004 ·Journal of Hepatology ·Alessandra Mangia, (unknown), Giorgio Ricci, Mario Romano, Vito Carretta, Marcello Persico, Donato Bacca, Federica Di Spirito, F. Vinelli, Mauro Annese, (unknown), Gaetano Scotto, Angelo Andriulli	6
5	Good Safety Profile and Efficacy of Leucocyte Interferon-?? in Combination with Oral Ribavirin in Treatment-Naive Patients with Chronic Hepatitis C 2003 ·BioDrugs ·Giuseppe Bárbaro, Benvenuto Grisorio, (unknown), Donato Bacca, Sergio Babudieri, Donato Torre, Ruggiero Francavilla, Giovanni Rizzo, G Belloni, Alfio Lucchini, Mauro Annese, (unknown), (unknown), Giorgio Barbarini	0
6	A randomised controlled trial on pegylated interferon alfa-2a (40kd) (Pegasys) or IFN alfa-2a (ROFERON-A) plus ribavrin (RBV) and amantadine (AMA) vs IFN alfa-2a and RBV in naïve patients with chronic HCV 2003 ·Journal of Hepatology ·Alessandra Mangia, (unknown), (unknown), Marcello Persico, Vito Carretta, Donato Bacca, (unknown), M.L. Piattelli, (unknown), Mauro Annese, Vincenzo Guadagnino, Federica Di Spirito, Angelo Andriulli	1
7	High doses of interferon in combination with ribavirin are more effective than the standard regimen in patients with HCV genotype 1 chronic hepatitis 2002 ·Journal of Hepatology ·Alessandra Mangia, Rosanna Santoro, (unknown), Gioacchino Leandro, Nicola Minerva, Mauro Annese, Donato Bacca, Fulvio Spirito, Vito Carretta, (unknown), (unknown), Angelo Andriulli	17
8	Long-term efficacy of interferon alpha-2b and lamivudine in combination compared to lamivudine monotherapy in patients with chronic hepatitis B. An Italian multicenter, randomized trial 2001 ·Journal of Hepatology ·Giuseppe Barbaro, F Zechini, Adriano Pellicelli, Ruggiero Francavilla, Gaetano Scotto, Donato Bacca, (unknown), Sergio Babudieri, Mauro Annese, (unknown), (unknown), Giorgio Barbarini	107
9	A Randomized Trial of Amantadine and Interferon Versus Interferon Alone As Initial Treatment for Chronic Hepatitis C 2001 ·Hepatology ·Alessandra Mangia, Nicola Minerva, Mauro Annese, Gioacchino Leandro, M Villani, Rosanna Santoro, Vito Carretta, Donato Bacca, (unknown), Michele Bisceglia, (unknown), (unknown), Angelo Andriulli	45
10	High sustained response rate after ribavirin + IFN retreatment of patients (PTS) who have failed a previous course of IFN with or without amantadine 2001 ·Journal of Hepatology ·Alessandra Mangia, (unknown), Mauro Annese, Vito Carretta, Donato Bacca, M Villani, Francesco Perri, (unknown), (unknown), (unknown), Angelo Andriulli	2
11	Interferon alpha-2b and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: a randomized trial 1999 ·The American Journal of Medicine ·Giuseppe Bárbaro, Gabriella Di Lorenzo, G Belloni, (unknown), (unknown), P. Del Poggio, Donato Bacca, (unknown), (unknown), Ruggiero Francavilla, Gaetano Scotto, Benvenuto Grisorio, Guido Calleri, Mauro Annese, (unknown), (unknown), Giovanni Rizzo, (unknown), (unknown), Giorgio Barbarini	59
12	Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: An italian multicenter double-blind, placebo-controlled, cross-over study 1998 ·Hepatology ·Giuseppe Bárbaro, Gabriella Di Lorenzo, Maurizio Soldini, Giuseppe Giancaspro, Giorgio Bellomo, G Belloni, Benvenuto Grisorio, Mauro Annese, Donato Bacca, Ruggiero Francavilla, Giorgio Barbarini	75
13	Interferon-α-2B and ribavirin in combination for chronic hepatitis C patients not responding to interferon-α alone: an italian multicenter, randomized, controlled, clinical study 1998 ·The American Journal of Gastroenterology ·Giuseppe Bárbaro, Gabriella Di Lorenzo, Maurizio Soldini, Giuseppe Giancaspro, Giorgio Bellomo, G Belloni, Benvenuto Grisorio, Mauro Annese, Donato Bacca, Ruggiero Francavilla, Giovanni Rizzo, Giorgio Barbarini	37
14	Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study. 1998 ·PubMed ·Giuseppe Bárbaro, Gabriele Di Lorenzo, Maurizio Soldini, Megan E. Marziali, Giovanni Bellomo, G Belloni, Benvenuto Grisorio, Mauro Annese, Donato Bacca, Giorgio Barbarini	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact